Medical Needs partner Atlantic Healthcare announces start of pivotal PhIII trial with alicaforsen in pouchitis


Study of fast-tracked and orphan designated alicaforsen is the largest ever in pouchitis, and aims to confirm efficacy in antibiotic refractory patients

Read full pressrelease here